• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测临床淋巴结阴性的甲状腺微小乳头状癌中的大容量淋巴结转移:一项回顾性研究。

Predicting large-volume lymph node metastasis in the clinically node-negative papillary thyroid microcarcinoma: a retrospective study.

作者信息

Shen Guohua, Ma Huan, Huang Rui, Kuang Anren

机构信息

Department of Nuclear Medicine, Laboratory of Clinical Nuclear Medicine, West China Hospital, Sichuan University.

Sichuan New Radiopharmaceuticals Technology Co. LTD., Chengdu, People's Republic of China.

出版信息

Nucl Med Commun. 2020 Jan;41(1):5-10. doi: 10.1097/MNM.0000000000001119.

DOI:10.1097/MNM.0000000000001119
PMID:31764592
Abstract

OBJECTIVE

Large-volume lymph node metastasis (LNM) has been believed to be an important predictor for recurrence in papillary thyroid microcarcinoma (PTMC). However, the clinical predictors for large-volume LNM have yet to be established. This study aimed to determine clinical predictors for large-volume LNM in clinically node-negative PTMC.

METHODS

A total of 947 clinically N0 PTMC patients who received total thyroidectomy with lymph node dissection and radioiodine therapy were included. Based on the LNM status, they were divided into two groups: large-volume LNM and small-volume LNM including those patients without LNM. The association between age, gender and other clinical factors and large-volume LNM were investigated. The recurrence-free survival was also compared among these groups.

RESULTS

We found that male gender [odds ratio (OR) = 1.865, P = 0.015], young age (OR = 2.743, P < 0.001) and extrathyroid extension (OR = 5.352, P < 0.001) were independent predictors for high prevalence of large-volume LNM. Young (<40 years) and male patients tended to have large-volume LNM with the highest prevalence of 17.20%, whereas old (≥55 years) and female patients had the lowest prevalence of 2.02%. After median follow-up of 71 months, the recurrence rate was significantly higher for large-volume LNM compared with small-volume LNM (15.48 vs 0.72%, P < 0.05). Large-volume LNM status was significantly associated with decreased recurrence-free probability, while small-volume LNM had little effect on the recurrence-free survival.

CONCLUSIONS

This study showed that in clinically node-negative PTMC, young male patients had a greater incidence of large-volume LNM.

摘要

目的

大量淋巴结转移(LNM)被认为是甲状腺微小乳头状癌(PTMC)复发的重要预测指标。然而,大量LNM的临床预测因素尚未确立。本研究旨在确定临床淋巴结阴性PTMC中大量LNM的临床预测因素。

方法

共纳入947例接受甲状腺全切除术加淋巴结清扫及放射性碘治疗的临床N0期PTMC患者。根据LNM状态,将他们分为两组:大量LNM组和少量LNM组(包括无LNM的患者)。研究年龄、性别和其他临床因素与大量LNM之间的关联。还比较了这些组之间的无复发生存率。

结果

我们发现男性[比值比(OR)=1.865,P=0.015]、年轻(OR=2.743,P<0.001)和甲状腺外侵犯(OR=5.352,P<0.001)是大量LNM高发生率的独立预测因素。年轻(<40岁)男性患者倾向于有大量LNM,发生率最高为17.20%,而老年(≥55岁)女性患者发生率最低为2.02%。中位随访71个月后,大量LNM组的复发率显著高于少量LNM组(15.48%对0.72%,P<0.05)。大量LNM状态与无复发概率降低显著相关,而少量LNM对无复发生存几乎没有影响。

结论

本研究表明,在临床淋巴结阴性的PTMC中,年轻男性患者大量LNM的发生率更高。

相似文献

1
Predicting large-volume lymph node metastasis in the clinically node-negative papillary thyroid microcarcinoma: a retrospective study.预测临床淋巴结阴性的甲状腺微小乳头状癌中的大容量淋巴结转移:一项回顾性研究。
Nucl Med Commun. 2020 Jan;41(1):5-10. doi: 10.1097/MNM.0000000000001119.
2
Young Age and Male Sex Are Predictors of Large-Volume Central Neck Lymph Node Metastasis in Clinical N0 Papillary Thyroid Microcarcinomas.年轻和男性是临床 N0 甲状腺微小乳头状癌中央区淋巴结转移大容量的预测因子。
Thyroid. 2017 Oct;27(10):1285-1290. doi: 10.1089/thy.2017.0250. Epub 2017 Aug 17.
3
Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3607 patients at a single institution.甲状腺微小乳头状癌淋巴结转移及生存率的临床预测因素:单中心3607例患者分析
J Surg Res. 2018 Jan;221:128-134. doi: 10.1016/j.jss.2017.08.007. Epub 2017 Sep 19.
4
Predictive Factors of Lateral Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.甲状腺微小乳头状癌侧颈部淋巴结转移的预测因素。
Pathol Oncol Res. 2019 Jul;25(3):1245-1251. doi: 10.1007/s12253-018-0511-8. Epub 2018 Oct 26.
5
Risk factors for central neck lymph node metastasis of clinically noninvasive, node-negative papillary thyroid microcarcinoma.临床无侵袭性、淋巴结阴性的甲状腺微小乳头状癌中央区颈部淋巴结转移的危险因素
Am J Surg. 2014 Sep;208(3):412-8. doi: 10.1016/j.amjsurg.2013.10.032. Epub 2014 Feb 10.
6
The impact of coexistent Hashimoto's thyroiditis on lymph node metastasis and prognosis in papillary thyroid microcarcinoma.并存的桥本甲状腺炎对甲状腺微小乳头状癌淋巴结转移及预后的影响
Tumour Biol. 2016 Jun;37(6):7685-92. doi: 10.1007/s13277-015-4534-4. Epub 2015 Dec 21.
7
Clinical and Pathologic Predictors of Lymph Node Metastasis and Recurrence in Papillary Thyroid Microcarcinoma.甲状腺微小乳头状癌淋巴结转移及复发的临床和病理预测因素
Thyroid. 2016 Jun;26(6):807-15. doi: 10.1089/thy.2015.0429. Epub 2016 May 17.
8
Clinical features and therapeutic outcomes of patients with papillary thyroid microcarcinomas and larger tumors.甲状腺微小乳头状癌和较大肿瘤患者的临床特征及治疗结果
Nucl Med Commun. 2019 May;40(5):477-483. doi: 10.1097/MNM.0000000000000991.
9
Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.甲状腺微小乳头状癌手术的临床病理特征、预后及其与BRAFV600E突变状态和血管生成因子表达的关系
PLoS One. 2016 Dec 9;11(12):e0167414. doi: 10.1371/journal.pone.0167414. eCollection 2016.
10
Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections.甲状腺微小乳头状癌隐匿性淋巴结转移:551 例切除术研究。
Surgery. 2010 Sep;148(3):526-31. doi: 10.1016/j.surg.2010.01.003. Epub 2010 Mar 2.

引用本文的文献

1
A radiopathomics model for predicting large-number cervical lymph node metastasis in clinical N0 papillary thyroid carcinoma.一种用于预测临床N0期乳头状甲状腺癌大量颈部淋巴结转移的放射组学模型。
Eur Radiol. 2025 Jan 29. doi: 10.1007/s00330-025-11377-8.
2
A prediction model for identifying high-risk lymph node metastasis in clinical low-risk papillary thyroid microcarcinoma.临床低危甲状腺微小乳头状癌中淋巴结高危转移的预测模型。
BMC Endocr Disord. 2023 Nov 27;23(1):260. doi: 10.1186/s12902-023-01521-0.
3
Ultrasound radiomics nomogram for predicting large-number cervical lymph node metastasis in papillary thyroid carcinoma.
用于预测甲状腺乳头状癌大量颈部淋巴结转移的超声影像组学列线图
Front Oncol. 2023 Jun 8;13:1159114. doi: 10.3389/fonc.2023.1159114. eCollection 2023.
4
Nomogram for preoperative prediction of high-volume lymph node metastasis in the classical variant of papillary thyroid carcinoma.用于术前预测经典型甲状腺乳头状癌高容量淋巴结转移的列线图
Front Surg. 2023 Feb 8;10:1106137. doi: 10.3389/fsurg.2023.1106137. eCollection 2023.
5
The risk of central nodal metastasis based on prognostic factors of the differentiated thyroid carcinoma: a systematic review and meta-analysis study.基于分化型甲状腺癌预后因素的中央区淋巴结转移风险:一项系统评价和荟萃分析研究。
Eur Arch Otorhinolaryngol. 2023 Jun;280(6):2675-2686. doi: 10.1007/s00405-023-07863-8. Epub 2023 Feb 10.
6
Related factor analysis for predicting large-volume central cervical lymph node metastasis in papillary thyroid carcinoma.预测甲状腺乳头状癌中央颈侧区大容量淋巴结转移的相关因素分析。
Front Endocrinol (Lausanne). 2022 Aug 15;13:935559. doi: 10.3389/fendo.2022.935559. eCollection 2022.
7
Development of an Active Surveillance or Surgery Model to Predict Lymph Node Metastasis in cN0 Papillary Thyroid Microcarcinoma.开发一种主动监测或手术模型,以预测 cN0 期甲状腺微小乳头状癌的淋巴结转移。
Front Endocrinol (Lausanne). 2022 Jul 22;13:896121. doi: 10.3389/fendo.2022.896121. eCollection 2022.
8
A novel tool for predicting the risk of central lymph node metastasis in patients with papillary thyroid microcarcinoma: a retrospective cohort study.一种用于预测甲状腺微小乳头状癌患者中央区淋巴结转移风险的新工具:一项回顾性队列研究。
BMC Cancer. 2022 Jun 2;22(1):606. doi: 10.1186/s12885-022-09655-5.
9
Predictive Factor of Large-Volume Central Lymph Node Metastasis in Clinical N0 Papillary Thyroid Carcinoma Patients Underwent Total Thyroidectomy.接受甲状腺全切术的临床N0期乳头状甲状腺癌患者发生大容量中央淋巴结转移的预测因素
Front Oncol. 2021 May 19;11:574774. doi: 10.3389/fonc.2021.574774. eCollection 2021.